External validation of a machine learning-based classification algorithm for ambulatory heart rhythm diagnostics in pericardioversion atrial fibrillation patients using smartphone photoplethysmography: the SMARTBEATS-ALGO study

The aim of this study was to perform an external validation of an automatic machine learning (ML) algorithm for heart rhythm diagnostics using smartphone photoplethysmography (PPG) recorded by patients with atrial fibrillation (AF) and atrial flutter (AFL) pericardioversion in an unsupervised ambula...

Full description

Saved in:
Bibliographic Details
Published inEuropace (London, England) Vol. 27; no. 4
Main Authors Fernstad, Jonatan, Svennberg, Emma, Åberg, Peter, Kemp Gudmundsdottir, Katrin, Jansson, Anders, Engdahl, Johan
Format Journal Article
LanguageEnglish
Published England Oxford University Press 28.03.2025
Subjects
Online AccessGet full text
ISSN1099-5129
1532-2092
1532-2092
DOI10.1093/europace/euaf031

Cover

More Information
Summary:The aim of this study was to perform an external validation of an automatic machine learning (ML) algorithm for heart rhythm diagnostics using smartphone photoplethysmography (PPG) recorded by patients with atrial fibrillation (AF) and atrial flutter (AFL) pericardioversion in an unsupervised ambulatory setting. Patients undergoing cardioversion for AF or AFL performed 1-min heart rhythm recordings pericardioversion at least twice daily for 4-6 weeks, using an iPhone 7 smartphone running a PPG application (CORAI Heart Monitor) simultaneously with a single-lead electrocardiogram (ECG) recording (KardiaMobile). The algorithm uses support vector machines to classify heart rhythm from smartphone-PPG. The algorithm was trained on PPG recordings made by patients in a separate cardioversion cohort. Photoplethysmography recordings in the external validation cohort were analysed by the algorithm. Diagnostic performance was calculated by comparing the heart rhythm classification output to the diagnosis from the simultaneous ECG recordings (gold standard). In total, 460 patients performed 34 097 simultaneous PPG and ECG recordings, divided into 180 patients with 16 092 recordings in the training cohort and 280 patients with 18 005 recordings in the external validation cohort. Algorithmic classification of the PPG recordings in the external validation cohort diagnosed AF with sensitivity, specificity, and accuracy of 99.7%, 99.7% and 99.7%, respectively, and AF/AFL with sensitivity, specificity, and accuracy of 99.3%, 99.1% and 99.2%, respectively. A machine learning-based algorithm demonstrated excellent performance in diagnosing atrial fibrillation and atrial flutter from smartphone-PPG recordings in an unsupervised ambulatory setting, minimizing the need for manual review and ECG verification, in elderly cardioversion populations. Clinicaltrials.gov, NCT04300270.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Conflict of interest: J.F. is the creator and founder of Corai and has received a scholarship from Boehringer Ingelheim, a research grant from AstraZeneca and lecture fees from Pfizer. E.S. is supported by the Stockholm County Council (clinical researcher appointment), the Swedish Research Council (grant number 2022–01466), the Swedish Heart Lung Foundation, and CIMED, and has received lecture fees from Abbott, Bayer, Bristol-Myers Squibb-Pfizer, Boehringer Ingelheim, Johnson & Johnson, and Merck Sharp & Dohme. K.K.G. has received research grants from Roche Diagnostics and the Swedish Heart Lung Foundation and lecture fees from Roche Diagnostics and Boehringer-Ingelheim. A.J. has received lecture fees from Boehringer Ingelheim, Pfizer and Merck Sharp & Dohme. J.E. has received consultant or lecture fees from Roche Diagnostics, Pfizer, Bristol Myers Squibb, Boehringer Ingelheim, Piotrode, and Philips, and research grants from the Swedish Research Council, the Swedish Heart Lung Foundation, VINNOVA, and the Stockholm County Council. P.Å. reports having nothing to declare.
ISSN:1099-5129
1532-2092
1532-2092
DOI:10.1093/europace/euaf031